Erik C Dreaden, PhD
Prior to joining Georgia Tech and Emory School of Medicine in 2017, Dr. Dreaden completed his postdoctoral training at the Koch Institute for Integrative Cancer Research at MIT, where his work sought to apply polymer engineering to improve the therapeutic potential of nucleic acid and rational combination and cancer therapies. His PhD training at Georgia Tech was likewise application-directed, focusing on the development of multivalent and photo-activated targeted cancer therapies based on nanoscale colloids. He is a native Atlantan and a life-long Braves fan.
- Kirschstein Postdoctoral Fellow – Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- PhD – Chemistry & Biochemistry, Georgia Institute of Technology
- BS – Chemistry, University of Georgia